Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term hepatitis B antibody persistence and challenge response study in previously vaccinated adolescents
2012-003950-10Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by GSK. Primary endpoint: Evaluation of anti-HBs immune status in terms of antibody concentrations. Started Jan 2013; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2012-003950-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003950-10.